Andrew Lane is Executive Vice President, Established Pharmaceuticals, leading Abbott's branded-generic medicines business. In this role, Andrew sets the strategic vision for his organization. He leads the effort to deliver high-quality, affordable medicines and innovative services to consumers, contributing to Abbott's mission of helping people live their best possible lives. He was appointed to his current role in March 2017. Prior to that, Andrew had served as Senior Vice President, Established Pharmaceuticals, Emerging Markets, and Divisional Vice President, Asia Pacific, for Established Pharmaceuticals. Prior to Abbott, he was Vice President of Asia Pacific at Takeda Pharmaceuticals. During his 20-year career in emerging markets, Andrew held country and regional positions at Nycomed, Invida, DKSH, Novartis and Sandoz, gaining experience both in the proprietary and branded generics business. He studied at University of Technology, Auckland, New Zealand receiving diplomas in both Business Management and Accounting.

Business Management and Accounting